Rohan Lall, MD, was the first to use SynerFuse's spinal implant in a solo procedure, the medtech company said Nov. 9.
Dr. Lall's surgery is the eighth in SynerFuse's proof-of-concept study combining spinal fusion with the implant of a neurostimulator, according to a news release. He has been involved in previous cases as part of the study.
"So far in the study, the SynerFuse procedure has been efficient and straightforward to perform," Dr. Lall said in the release. "The industry has seen the efficacy of DRG stimulation for patients with chronic pain, and it is very exciting to be able to study incorporating it earlier in the treatment process for these patients in an attempt to reduce their pain levels and needs for opioids."
SynerFuse's proof of concept study supports the enrollment of up to 20 patients. The procedure is designed to address chronic lower back pain. Michael Park, MD, PhD, and Jonathon Sembrano, MD, have also completed SynerFuse procedures during the study.